CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 56 enrolled
Drug / intervention
Regular Titration +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00382291
NCT00382291Phase 4Completed
CompareCT.gov

SSRI-Induced Activation Syndrome in Pediatric Obsessive Compulsive Disorder

University of Florida·interventional·Posted Sep 29, 2006·Updated Mar 12, 2013

In Brief

A Phase 4 clinical trial evaluating Regular Titration, Placebo, and 1 other intervention for Obsessive-Compulsive Disorder. Completed, enrolled 56 participants across 2 sites.

Detailed Summary

This study measures the occurrence of certain side effects linked to antidepressant use and evaluates the effectiveness of the medication sertraline plus cognitive behavioral therapy to treat people with obsessive-compulsive disorder.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObsessive-Compulsive Disorder
CountriesUnited States
CollaboratorsNational Institute of Mental Health (NIMH)

Timeline

Phase 4CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 29, 2006
Enrollment StartFeb 1, 2009
Primary CompletionFeb 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 19.8 years ago

Interventions

Regular Titrationdrug

Sertraline will be administered in standard dosing. Treatment with sertraline will last 18 weeks.

Placebodrug

The placebo will be administered in the same manner as sertraline. Treatment with placebo will last 18 weeks.

Slow Titrationdrug

Sertraline will be administered in slow titration. Treatment with sertraline will last 18 weeks.